FDA approves first-of-its-kind robotic device designed to automatically draw blood from patients

WASHINGTON — The U.S. Food and Drug Administration on Wednesday authorized the first standalone robotic device that can draw blood from a patient’s arm without a hands-on operator.

The device, called Aletta, was designed by Vitesro, a medical robotics company based in the Netherlands.

Aletta performs most of the blood-draw process and automates it, while a trained phlebotomist supervises. The FDA said a phlebotomist can oversee up to three devices at once.

1. Homepage
2. Kare 11
3. FDA approves first-of-its-kind robotic device designed to automatically draw blood from patients